Trinity Biotech PLC (TRIB)
1.685
-0.06
(-3.71%)
USD |
NASDAQ |
May 02, 16:00
1.685
0.00 (0.00%)
After-Hours: 19:16
Trinity Biotech 1 Year Total Returns (Daily): -68.18% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -68.18% |
April 30, 2024 | -65.49% |
April 29, 2024 | -66.25% |
April 26, 2024 | -64.47% |
April 25, 2024 | -64.81% |
April 24, 2024 | -65.14% |
April 23, 2024 | -67.32% |
April 22, 2024 | -67.68% |
April 19, 2024 | -60.32% |
April 18, 2024 | -56.28% |
April 17, 2024 | -57.21% |
April 16, 2024 | -55.84% |
April 15, 2024 | -54.53% |
April 12, 2024 | -56.74% |
April 11, 2024 | -57.44% |
April 10, 2024 | -53.80% |
April 09, 2024 | -55.14% |
April 08, 2024 | -54.31% |
April 05, 2024 | -54.23% |
April 04, 2024 | -54.54% |
April 03, 2024 | -54.18% |
April 02, 2024 | -58.30% |
April 01, 2024 | -58.51% |
March 28, 2024 | -54.67% |
March 27, 2024 | -55.51% |
Date | Value |
---|---|
March 26, 2024 | -56.79% |
March 25, 2024 | -54.87% |
March 22, 2024 | -54.66% |
March 21, 2024 | -53.27% |
March 20, 2024 | -52.17% |
March 19, 2024 | -49.79% |
March 18, 2024 | -50.14% |
March 15, 2024 | -53.33% |
March 14, 2024 | -53.19% |
March 13, 2024 | -53.75% |
March 12, 2024 | -52.99% |
March 11, 2024 | -54.02% |
March 08, 2024 | -55.40% |
March 07, 2024 | -57.22% |
March 06, 2024 | -58.27% |
March 05, 2024 | -60.00% |
March 04, 2024 | -59.05% |
March 01, 2024 | -57.43% |
February 29, 2024 | -58.67% |
February 28, 2024 | -58.29% |
February 27, 2024 | -56.19% |
February 26, 2024 | -57.41% |
February 23, 2024 | -55.96% |
February 22, 2024 | -62.05% |
February 21, 2024 | -54.46% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.83%
Minimum
Feb 16 2022
609.7%
Maximum
Mar 18 2021
4.05%
Average
-41.95%
Median
Oct 28 2022
1 Year Total Returns (Daily) Benchmarks
Avadel Pharmaceuticals PLC | 56.10% |
Amarin Corp PLC | -39.86% |
DBV Technologies SA | -55.66% |
Adaptimmune Therapeutics PLC | -16.08% |
Akari Therapeutics PLC | -54.05% |